Black Carbon Loading in Sputum and Bronchoalveolar Lavage Macrophages as a Biomarker of Air Pollution Exposure by Tillery, Anna
 1 
 
 
 
 
 
 
Black Carbon Loading in Sputum and Bronchoalveolar Lavage Macrophages as a 
Biomarker of Air Pollution Exposure 
 
 
 
 
 
 
Anna Tillery 
 
 
Honors Thesis ENHS 
Department of Environmental Sciences and Engineering 
Gillings School of Global Public Health 
The University of North Carolina at Chapel Hill 
April, 2019 
 
 
 
 
 
 
 
  
 2 
ACKNOWLEDGEMENTS 
 
This project would not be possible without the Center for Environmental Medicine, 
Asthma, and Lung Biology. I would like to thank Dr. Neil Alexis for the support and guidance 
offered throughout the project. In addition, thank you to all of whom work in Dr. Alexis’s lab, 
specifically Heather Wells and Ceolamar Ways for providing assistance and advice where 
necessary within and outside of this project. The support and encouragement of everyone 
involved helped make this project, and my personal growth, possible.  
  
 3 
ABSTRACT 
 
 Previous literature has proven that black carbon (BC) can be used as a biomarker for 
long-term personal exposures to particulate matter air pollution from measurements of 
particulates within airway macrophages (Macs). Macs can be collected by, Bronchoalveolar 
Lavage (BAL) and Sputum. Sputum samples are preferred within research because they are 
inexpensive and less-invasive compared to BAL. Due to the differences in location of Macs 
collected in the lungs from the two collection types, there is the potential for differential BC 
deposition and uptake by Macs. To fill this gap in research, we are interested in observing the 
differences in BC content between Macs derived from sputum samples versus BAL through 
image analysis to determine if both are equally viable forms of collection for use as a biomarker 
for air pollution exposure through BC assessment. ANOVA testing showed that there were little 
significant differences between BC content in Macs collected from Sputum and BAL. Because 
results have shown no significant differences in BC uptake between Sputum and BAL Macs, 
sputum sample results are equally viable to research as BAL results. 
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INTRODUCTION 
 
 Black carbon (BC) is a byproduct of fossil fuel combustion and a component of particulate 
matter (PM) air pollution, usually comprising PM of 2.5 µm and below.1,2 Exposure to BC in air 
pollution is associated with an amalgam of adverse health outcomes such as chronic respiratory 
diseases and lung cancers. Additionally, BC is thought to be a sufficient biomarker of exposure to 
fossil fuel (such as diesel and gasoline fumes) and other PM air pollution.3,4 It has been previously 
determined that BC content in airway macrophages is effective for assessing personal exposure to 
PM air pollution in cases of long-term exposures (either months or years).5 Simple air-quality 
monitoring at fixed locations only conveys external exposures to air pollution within a certain mile 
radius, while biomonitoring and assessment of effective biomarkers indicates internal and personal 
exposures. Because of this, biomonitoring provides a deeper understanding of a subject’s 
individual exposure to air pollution and its associated risks.    
Macrophages (Macs) either reside on the airway lumen or below the epithelial cell barrier 
of the lung and are the first response of immune defense.6 Phagocytosis of PM by Macs is rapid 
and occurs to completion within 24 hours of exposure.6 Particulates in air pollution generally range 
from 2-10 µm in diameter and have shown to deposit preferentially in the bronchial airways over 
alveolar airways.7 It has been previously determined that phagocytes (macrophages, neutrophils, 
monocytes) residing in the bronchial airways exhibit increased inflammatory cell function, 
specifically increased levels of surface-receptors mediating phagocytosis, compared to those in the 
alveolar airways, but it has not been examined in relation to BC uptake whether these cells function 
differently.7 
Assessment of BC as a biomarker is examined by measuring its content inside macrophages 
acquired from sputum induction or bronchoalveolar lavage (BAL); both BAL and induced sputum 
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samples have difficulties and benefits for collection of samples and ease of measurement of BC. 
PM deposits differently within the lung depending on several factors including its size. Ultrafine 
PM (<2.5 µm) deposits further within the lungs which has led to BAL macrophages exhibiting 
smaller size distributions of phagocytized particles than sputum macrophages.5 BAL samples have 
been shown to contain more homogenous samples in terms of macrophage phenotype and yield 
greater numbers of macrophages than sputum samples.7 Sputum induction samples the surfaces of 
the bronchial airways whereas BAL samples derive  from the peripheral, alveolar airways; because 
of this, BAL and Sputum samples acquire different kinds of Macs, either from the large, central 
airways for Sputum or from the distal airways for BAL.8 BAL is an invasive procedure that 
requires the use of anesthesia within a hospital suite compared to the less-invasive sputum 
induction procedure which uses hypertonic saline solution and can be performed safely by a trained 
professional outside of hospitals. Historically, BAL collection has provided more reliable 
measurements and a greater number of Macs while Sputum induction is easier and more cost-
efficient, although the methods have not yet been compared for their use in BC measurements.5 
The purpose of this study is to compare BC in Sputum and BAL derived Macs in order to 
assess the efficacy of each method for biomarker application to PM exposure. This assessment will 
give insight into whether BAL and sputum are equally effective techniques for examining BC 
content of macrophages. Additionally, we will be able to determine if bronchial macrophages 
exhibit different BC uptake than alveolar macrophages. In order to accomplish this, stained BAL 
and sputum cytospin slides from the same subject were assessed for macrophage BC content using 
light microscopy and Image J software. We examined the difference in BC content and deposition 
in Macs within the two sample types.  
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METHODOLOGY 
 
SUBJECTS AND SAMPLE COLLECTION 
 
 Subjects were selected from the SubPopulations and Intermediate Outcome Measures in 
COPD Study (SPIROMICS). SPIROMICS collected samples, including sputum and 
bronchoalveolar lavage, from COPD patients at several institutions in the United States. UNC 
Chapel Hill Center for Environmental Medicine, Asthma, and Lung Biology (CEMALB) 
participated in SPIROMICS as a central sputum slide reading core. Sputum slides and BAL 
cytospin slides from the same subject were acquired from various institutions participating in the 
SPIROMICS bronchoscopy sub-study and were examined for BC. Twenty subjects’ matched 
sputum and BAL slides were assessed for macrophage BC. Subjects were excluded if they did not 
participate in both Sputum and BAL collection.  
 Sputum induction and processing was performed according to the SPIROMICS manual of 
operation (MOP V5). Sputum induction was performed using a Devilbiss Ultra-Neb 99 Ultrasonic 
Nebulizer, and a spirometer was used to assess forced expiratory volume (FEV1). Two induction 
protocols were employed depending on the post bronchodilator baseline FEV1. If the post 
bronchodilator FEV1 of the subject was greater than 1 liter, the induction procedure was 
performed. The induction procedure followed this protocol: 15 mL of 3% saline solution in the 
nebulizer for 2 minutes, then spirometry was run to determine if the subject was able to continue, 
if so, the nebulizer was continued for 5 minutes. After induction, the subject attempted to cough 
up sputum until they could no longer do so. Spirometry was repeated, and if the subject remained 
stable, the process was repeated with 15 mL of 4% saline solution. The subject attempted to cough 
again, spirometry was repeated, and if stable, they continued with 15 mL of 5% saline. The subject 
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attempted to cough up the resulting sputum without scraping their throat, and the sample was sent 
for processing.  
If the post bronchodilator FEV1 was less than 1 liter, the nebulizer was filled with 15 mL 
of 0.9% saline solution. Spirometry was performed at 1, 2, 5, and 7 minutes, gathering the induced 
sputum at the end of the 7 minutes. The subject always attempted to cough up the induced sputum 
without scraping their throat. At the spirometry checks, if the FEV1 fall from baseline was between 
10-19%, the procedure could continue with the same saline concentration. If the FEV1 fall from 
baseline was < 10%, the saline concentration could be increased to the next highest concentration.   
 Sputum processing occurred using the whole sample. The sample was weighed and 0.1% 
dithiothreitol (DTT) was added equaling 4 times the sputum weight. Sample was vortexed and 
tumbled for 15 minutes, then ethylenediaminetetraacetic acid (EDTA) was added in the same 
volume of DTT previously added. Sample was tumbled for 5 minutes and filtered through a 53µm 
nylon mesh filter. Cells were spun down at 500xg for 10 minutes and 1-2 mL of Hank’s Balanced 
Salt Solution (HBSS) then counted. Sample was adjusted to a concentration of 1.0*10^6 cell per 
mL of HBSS media and slides were prepared with 60 µL of sample and spun at 450 rpm for 6 
minutes. Slides were stained with Hema 3 stain set, mounted with Cytoseal and coverslips and 
stored at room temperature.  
 Bronchoscopy sample collection occurred after the subject was treated with anesthesia. 
The bronchoscope was safely inserted, and the airways of the subject were deemed normal enough 
to continue. The BAL was performed in the lower lobe bronchus. In the first segment, sterile saline 
was injected in 2x40cc and then 1x50cc. If less than 15cc of fluid was returned, the 1x50cc wash 
was not performed. Then, the bronchoscope was moved to another segment and the washes were 
repeated. The BAL return was collected in lidocaine-free specimen traps and stored on ice until 
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processing. The BAL fluid was centrifuged at 500xg for 10 minutes and the supernatant was stored. 
The cell pellet was resuspended in 10 mL of Roswell Park Memorial Institute (RPMI) media. 
Hemacytometry was performed to determine cell count and viability; 4 cytospin slides were 
prepared after the sample was adjusted to a concentration of 1.0*10^6 cell per mL of media. The 
slides were prepared with 60 µL of sample and spun at 450 rpm for 6 minutes. They were then 
fixed with 95% ethanol and stored at room temperature.  
  
BLACK CARBON 
 
 BC was measured using NIS Elements Imaging Software Basic Research 5.00.00. Pictures 
of macrophages were taken on a Life Technologies evos XL core microscope. For each subject, a 
minimum of 50 macrophages were photographed and read on each of their sputum and BAL slides. 
If 50 macrophages were not found on the slide, the subject slide was included if total macrophages 
counted and photographed exceeded 30. Macrophages were included for measurement if they had 
an intact cell wall and features easily discernable on a microscope. BC was measured manually, 
measurements included carbon deposits in the nucleus and the cytoplasm following the protocol 
previously described in Jary et.al.9 NIS Elements recorded the total macrophages counted, the BC 
area, in µm2, per macrophage [Objects Area (OA)], the number of BC deposits found in each 
macrophage [Number Objects (NO)], the % of BC occupying the interior of the macrophage  
[Objects Area Fraction (OAF)], and the average internal area, in µm2, of each macrophage 
measured [ROI Area]. Objects area fraction was calculated as follows: OAF = OA/ROI Area x 
100%. Black carbon deposits were included if they were completely or partially inside the Mac 
cell wall.   
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DATA ANALYSIS 
 
 Mean, standard deviation, minimum, and maximum values were measured for each 
parameter. Statistical analysis was performed using GraphPad Prism 8 for Windows 64-bit. A one-
way ANOVA was run with an assumption of a Gaussian distribution of residuals with an alpha 
level 0.05 and a Tukey post-Hoc analysis. The data were log transformed and an ANOVA test 
with the same assumptions and post-Hoc analysis was run. Data presented in graphs and figures is 
the non-transformed data. Pearson and Spearman correlation tests were also run on the total 
dataset.  
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RESULTS 
 
 Black Carbon (BC) was found in airway macrophages in all 20 subjects assessed, in both 
sputum and BAL slides. Figure 1 shows examples of phagocytized BC in Macs from a Sputum 
and BAL sample from one subject. Mean, standard deviation, minimum value and maximum value 
measured for total macrophages, object area fraction, object area, number of objects, and 
macrophage area for Sputum measurements are found in Table 1: Summary Characteristics of 
Sputum Measurements and BAL measurements are found in Table 2: Summary Characteristics of 
BAL Measurements from NIS Elements BC Measurements. This data is presented in graph form 
in Figure 2. 
 The ANOVA test found significant differences at alpha level 0.05 with a p value less than 
0.001. In the post-Hoc analysis, Sputum ROI Area was significantly different than BAL ROI Area. 
The remaining significant differences were between parameters of the same source, Sputum or 
BAL correlating with another parameter from Sputum or BAL; these significant differences were 
not of interest because we were not interested in looking to how the parameters compared within 
the same type of collection (i.e. Sputum OA to Sputum OAF). In terms of correlations, we found 
that Sputum OA and BAL NO were significantly correlated (R = 0.4, p = 0.05) and significant 
trends were observed between Sputum OA and BAL OA (R = 0.4, p = 0.08) and Sputum OAF and 
BAL NO (R = 0.4, p = 0.10) (Figure 3).  
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DISCUSSION 
 
The goal of this experiment was to ascertain whether Sputum and BAL are equally 
effective methods of data collection for use of BC as a biomarker for air pollution exposure. In 
previous literature, Sputum and BAL have been used independently for air pollution exposure 
assessment by BC but it has never been determined if they are both viable. This assessment needed 
to be done to better understand how BC deposits within the lungs and whether Macs derived from 
Sputum induction or BAL can both be used. The data gathered suggest that both forms of collection 
are equally viable for BC assessment and can be used in place of one another. This is advantageous 
for future research as Sputum induction is quicker, cheaper, and less invasive than BAL so it is a 
preferred method for human studies.  
The data demonstrate that on average Sputum macrophages are larger than BAL 
macrophages, and BC occupies a larger absolute internal area (µm2) of sputum macrophages versus 
BAL macrophages. However, when macrophage size was normalized by calculating the percent 
BC occupancy, we found that Sputum and BAL macrophages take up relatively similar amounts 
of BC. This was further shown when the number of BC deposits did not significantly differ 
between sputum and BAL macrophages. From this information, we know that BC can penetrate 
deep into the alveolar airways and can be phagocytosed by alveolar macrophages residing there.  
Another implication is that functionally, sputum macrophages are not inferior to BAL 
macrophages in terms of BC uptake, supporting earlier work by Alexis et al., that showed sputum 
macrophages had greater phagocytic capability than autologous alveolar macrophages.7 
Additionally, there were no other significant differences found between any parameters measured 
in either test besides the macrophage area. This indicates that both forms of collection are equally 
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viable when considering BC uptake and measurement meaning that either could be used for 
assessment of BC as a biomarker for future studies.  
Sputum OA and BAL NO were significant at an alpha of 0.05 indicating that as sputum 
OA increases, BAL NO also increases. Sputum OAF and BAL NO were trending towards 
significance, and there could be a positive correlation between the amount of BC in Sputum Macs 
and the NO found in BAL AM. All of these correlations show moderate correlations (Figure 3), 
although there are apparent outliers in the data, these correlations indicate that BC in Sputum and 
BAL are related to each other and increase at the same rates. Correlation tests also revealed that 
Sputum and BAL object areas trended towards significance. This correlation is logical because of 
the object areas similarity in absolute values, it would indicate that as Sputum BC area increased, 
BAL BC area also increased. This could show that BC uptake scales similarly in upper airway 
macrophages as well as alveolar macrophages and reveal how Macs take in carbon. This also 
indicates that Sputum Macs do not prevent BC from penetrating deep into the alveolar region of 
the lung, also supporting previous studies that have shown differential BC deposition within the 
lungs.10 The correlation data simply shows that Sputum and BAL BC content are related to each 
other in the sense that within subjects, higher content in Sputum Macs is associated with higher 
content in BAL Macs as well. This provides further evidence supporting Sputum and BAL as 
equally viable methods. As more subjects are included in the study, it should become apparent 
whether these correlations get stronger or grow further apart to understand if these correlations say 
something about BC in the lungs. It is also important to remember that these samples were not 
collected on the same day, and without ambient air pollution data these comparisons are not ideal.  
This data indicates that macrophages derived from the upper areas by Sputum collection 
and from the alveolar airways by BAL collection function in the same capacity when it comes to 
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BC uptake. While it has already been determined that sputum macrophages function comparably 
to BAL macrophages and Sputum can be used to collect biomarkers for disease, it has not been 
previously assessed whether this holds true for BC uptake as well.3,8 The data collected in this 
study have shown that BC uptake between Sputum and BAL macrophages shows no significant 
differences within the same subject, indicating that Sputum could be used in place of BAL. 
Because BAL is a much more expensive and invasive method to use for data collection, it is 
preferred to use Sputum as a method of data collection, especially for large sample sizes. Our data 
suggest that Macs in the bronchial and alveolar regions may function with the same capacity with 
regards to BC uptake, so data collected from Sputum and BAL methods should give the same 
information. Although, it is important to remember that samples were not taken on the same day 
so there is the potential for differing amounts of BC within the lungs. Samples are independent of 
each other so order of collection would not matter, solely the exposure to air pollution. This is 
important because it has been found that Macs produce reactive oxygen species in a dose-
dependent manner to their BC loading.11 Understanding how BC is taken up in Macs in relation to 
air pollution exposure is the first step to learning more about the health effects of BC on the body 
and how this relates to a person’s overall health.  
Varying sizes of PM deposit differently throughout the lungs. It has been found previously 
that PM with diameter of 3 µm preferentially deposits in the larger, proximal regions of the lungs 
while ultrafine PM (~1 µm) deposits throughout the lungs.10,12 It has also been shown that about 
80% of BC in the air is considered ultrafine PM while the remaining 20% is around 2-3 µm.13 It 
was thought originally that the differential deposition patterns would affect the rates of BC uptake 
within the lungs due to varying amounts present in the proximal and alveolar regions of the lungs, 
but the data presented indicates that this is not likely. The data suggests that Sputum Macs within 
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the large airways do not prevent BC from penetrating in the deep, alveolar region of the lung. This 
supports previous research stating that BC PM in ambient air pollution is comprised of different 
sizes. While BC may deposit differentially throughout the lungs, amount of BC does not seem to 
affect Macs uptake regardless of whether they were BAL or Sputum derived.  
Although these results are promising for use of Sputum BC as a biomarker for air pollution 
exposure, it is important to remember the subjects used in this study were COPD patients and not 
healthy. It has been previously determined that BC is taken up in healthy subjects and can be used 
as a biomarker for air pollution; it has also been found that Sputum macrophages can be hyper 
functional compared to BAL macrophages.3,7 If COPD patient’s macrophages are hyper functional 
in relation to BC uptake, this could affect their total lung function and potentially make the patient 
sicker. If unhealthy COPD subjects Macs focus too heavily on BC uptake rather than the full range 
of pathogens invading their lungs, there is a potential for them to get infections easier. We need to 
be able to understand how BC is affecting healthy and sick subjects and if BC uptake is differential. 
 Sputum and BAL samples taken from subjects were not collected on the same day. 
Therefore, this limitation hinders our ability to accurately assess whether BC concentrations within 
the subject’s lungs were the same. Because of this limitation, it is important to move on with the 
project and gather ambient air pollution data for each subject during the time of collection for each 
sample. An additional limitation to this study is the small sample size. Only 20 subjects were 
included in this study, while data collection continues for the project as a whole and more subjects 
are included, we will get a clearer understanding of the true population distribution of BC content.  
 Additionally, BC was measured manually and the process was not computerized. This adds 
the limitation of human error as the measurement was subjective to the author. This visual counting 
approach introduces the potential for either under or over reporting of BC content within the Macs. 
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Although this approach may have certain advantages over previous literature using computerized 
counts as it included BC deposits within the nucleus where many studies do not do so.   
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CONCLUSIONS 
 
 In summary, there have been no significant differences found between Sputum derived 
Macs and BAL derived Macs. Summary characteristics and analyses have shown that Sputum and 
BAL only significantly differ in size of macrophages found in the areas collected but that has not 
seemed to have an effect on capacity of Macs to load BC. This indicates that Sputum collection is 
equally as effective for deriving BC biomarker information as BAL collection for COPD patients 
although this should be investigated further to understand how this relates to PM air pollution 
exposure and whether this relationship differs with healthy subjects. 
 
FUTURE DIRECTIONS 
 
In the future, we will look to assess how this information relates to the air pollution 
exposure measurements for each subject on the days of their bronchoscopy/ sputum induction. It 
has previously been found that BC content in Macs is a better indicator of adverse health effects 
to the subject rather than PM mass in the air but the relationship has not been further investigated.14 
This information could tell us more about carbon uptake rates and correlations between the level 
of exposure and BC in sputum/BAL measurements, and provide further proof that BC in 
macrophages can be used as a biomarker for air pollution exposure. We would want to investigate 
whether BC uptake differs with air pollution exposure and if uptake rates differ with amount of 
BC in the body. This relationship has been investigated in regards to proximity to traffic patterns, 
and it has been found that increased proximity is associated with higher amounts of BC content in 
Macs, although this has not been investigated for simple ambient air pollution levels.15 This 
association has not been compared to differences between Sputum and BAL Macs either.  
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In addition, it would be interesting to see if this data is different for healthy subjects versus 
COPD subjects. We could look to see if there is a difference between carbon uptake in 
macrophages between the two types of subjects to determine if COPD patients are actually more 
prone to infections due to air pollution exposure. It has previously been shown that exposure to 
diesel exhaust particles inhibits immune functions due to the increased demand on macrophages 
phagocytosis to remove the particles which could support the hypothesis for BC affecting immune 
function in healthy and COPD subjects.16 If the BC uptake is differential for COPD and healthy 
patients further investigation would need to be done to determine if air pollution exposure plays a 
role in the overall health of COPD patients more so than healthy patients. Due to COPD patient’s 
already reduced lung function we would be interested in knowing whether BC has a greater health 
effects to them over healthy subjects.  
Additionally, it has been shown that PM deposition within the lungs is increased in the 
lungs of COPD patients over healthy, non-smoking patients.17 A previous study investigated the 
effects of BC loading in children with asthma compared to healthy children and found that with 
more severe cases of asthma, BC loading by Macs decreased.18 This could indicate a difference 
between COPD and healthy patients in terms of their Macs ability to load BC. It should be 
investigated to see whether this increased deposition of BC affects Macs phagocytosis and/or plays 
a role in the increased likelihood of infection of COPD patients. Previously, it has been found that 
BC/PM in COPD patients has greater retention within the lungs compared to that of healthy 
patients.19 Retention of BC also increases with disease severity of COPD subjects indicating that 
more health effects associated with PM in ambient air pollution would be seen in more severely 
affected patients.19 The differences in lung/ immune function and BC deposition between healthy 
and COPD subjects could change how BC is loaded by Macs and the effects it has on the body.   
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APPENDIX  
TABLES 
Summary Characteristics of Sputum Measurements from NIS Elements BC 
Measurements 
 
Total 
Macrophages 
Object Area 
Fraction [x 
100%] 
Objects 
Area [µm2] 
Number 
Objects 
Macrophage 
Area [µm2] 
Mean 
(SEM) 
60 (4.5) 15.9 (1.8) 100.5 (19.7) 16.3 (1.1) 594.3 (62.7) * 
Minimum 50 6.8 27.7 8.4 358.4 
Maximum 100 3.5 341.6 29.7 1522.5 
Table 1.  Summary characteristics of sputum black carbon measurements recorded from NIS Elements software. 
Measurements include the mean measurement for the 20 subjects along with the standard error of the mean, minimum, 
and maximum values. Total Macrophages indicates the average total number of Macs measured on the slide, Object 
Area Fraction indicates the average percent area cover of BC in the Macs, Objects Area indicates the average area of 
BC per Mac, Number Objects indicates the average number of BC deposits per Mac, and Macrophage Area indicates 
the average area of each Mac. 
*Indicates a statistically significant difference in compared measurements from Sputum to BAL 
 
Summary Characteristics of BAL Measurements from NIS Elements BC Measurements 
 
Total 
Macrophages 
Object Area 
Fraction [x 
100%] 
Objects 
Area [µm2] 
Number 
Objects 
Macrophage 
Area [µm2] 
Mean 
(SEM) 
49.4 (0.6) 15.8 (1.5) 64.8 (7.6) 19.1 (2.2) 417.3 (22.3) * 
Minimum 39 5.3 15.9 5.9 246.9 
Maximum 51 2.9 168 45.7 641.3 
Table 2. Summary characteristics of BAL black carbon measurements recorded from NIS Elements software. 
Measurements include the mean measurement for the 20 subjects along with the standard error of the mean, minimum, 
and maximum values. Total Macrophages indicates the average total number of Macs measured on the slide, Object 
Area Fraction indicates the average percent area cover of BC in the Macs, Objects Area indicates the average area of 
BC per Mac, Number Objects indicates the average number of BC deposits per Mac, and Macrophage Area indicates 
the average area of each Mac. 
*Indicates a statistically significant difference in compared measurements from BAL to Sputum 
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FIGURES 
 
Figure 1. Sputum (A and B) and BAL (C) macrophages from one COPD patient enrolled in SPIROMICS 
showing phagocytized BC. Arrows point to BC deposits. 
  
A. B. 
C. 
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Parameters Measured 
 
Figure 2. Mean of parameters measured with standard error of the mean. Parameters shown are the Object Area 
Fraction, Object Area, Macrophage Area, and Number of Objects. 
*Indicates a statistically significant difference between parameters  
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Sputum and BAL Correlations 
 
Figure 3. Correlations between sputum and BAL BC measurements. Correlations indicate how BC uptake in 
Sputum and BAL Macs are related.  
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